Atlas Trials

An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States

Clinical trial NCT06321055 · COMPLETED

Trial details

NCT number
NCT06321055
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Advanced Gastrointestinal Stromal Tumor
Start date
2024-03-01
Primary completion
2024-05-01
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.